4
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001209191-20-048651
Chief Commercial Officer acquired 5,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Muller Lorenz Chief Commercial Officer | 2020-08-26 | Option exercise | +5,700 | $1.54 | $8,778 | 108,386 | D |
| Derivatives | |||||||
| Muller Lorenz Chief Commercial Officer | 2020-08-26 | Option exercise · Employee Stock Option (right to buy) | −5,700 | 49,754 | D | ||
Loading xslF345X03/doc4.xml…